Supply chain and availabilitynegative · 4 filings
“GAAP Measures” for the reconciliation of net income (loss) attributable to Apollo Global Management, Inc.”10-Q · Aug 10, 2026 ↗
Apollo Global Management, Inc.
APO
Market read
Apollo Global Management, Inc.'s move is spreading beyond its market group.
APO accounts for 7.7% of the group's measured movement across 3.6 effective names. raw member direction is mixed; 0 of 12 SPY-adjusted paths align to the mixed. Capital-flow agreement is 2%, so confirmation is not yet clean. No verified headline preceded the measured group move.
MOVE ANATOMY
SPY-adjusted 5m pathsIs this move genuinely shared?
Role in the moveIndependent mover#4 of 12 by movement share
Group movement share7.7%Absolute path energy—not portfolio weight
Relative path+0.36%mixed
Effective breadth3.6 / 12concentrated
Relative alignment0/12mixed path · 0 counter-moving
Capital-flow agreement2%not yet clean
SEQUENCE READ
APO was the first measured mover. APO crossed its material path threshold at 10:25 ET. ABT, ATRC, ARES followed.
EVIDENCE COVERAGE
7 of 27 members in Biopharmaceuticals and Care are active. 1 of 8 disclosed connections are confirming.
What would change this read
Watch this read- At least 18 of 27 durable members become active together.
- Capital-flow agreement rises above 55%.
- MFIC remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 9 of 27 members or fewer.
Research brief
The story so far
APO accounts for 7.7% of the group's measured movement across 3.6 effective names. raw member direction is mixed; 0 of 12 SPY-adjusted paths align to the mixed. Capital-flow agreement is 2%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Evidence that supports
No thresholded supportive filing evidence is available yet.
Evidence that challenges
No thresholded adverse filing evidence is available yet.
What would clarify the read
- At least 18 of 27 durable members become active together.
- Capital-flow agreement rises above 55%.
- MFIC remains aligned with the group in the next market snapshot.
Company research
Understand the business, not just the ticker
Business model and earnings drivers
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
Key research questions
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
Annual periods6
Price observations620
Usable filing statements223
Verified relationships12
Evidence supporting the case
- Latest annual revenue changed +22.7% year over year.
- Operating cash flow covered net income at 2.08x in the latest annual period.
Evidence challenging the case
- Net margin changed -6.6 percentage points in the latest annual period.
- Supply chain and availability has repeated adverse evidence across 4 filings.
Questions before a position
No credible peer-relative valuation comparison is available yet.
Longer-term price context
Price as of Oct 7, 2026
115.586m+8.0%12m-8.8%24m-13.0%
Annual trajectory
Reported annual revenue and per-share history. This is accounting history, not a forecast.
PeriodRevenueYoYDiluted EPSShare change
2021-12-31$6.0B+152.8%$7.32+4.0%
2022-12-31$11.0B+84.3%$-3.43—
2023-12-31$32.6B+197.6%$8.28+0.7%
2024-12-31$26.1B-20.0%$7.33+2.6%
2025-12-31$32.0B+22.7%$5.54-1.7%
What management says matters
Persistent and emerging business drivers
Credit and interest ratespositive · 2 filings
“The AHL credit facility has a commitment termination date of June 30, 2028, subject to up to two one-year extensions, and was undrawn as of March 31, 2026.”10-Q · May 7, 2026 ↗
Foreign exchangemixed · 2 filings
“The unrealized foreign exchange losses on foreign-denominated assets were primarily attributable to the strengthening of the U.S.”10-Q · May 7, 2026 ↗
Restructuring and cost reductionsnegative · 2 filings
“The lower returns from origination platforms were mainly attributable to outsized performance from MidCap FinCo and Redding Ridge in 2025, as well as market headwinds impacting the valuation of each in 2026, a valuation increase related to strong performance…”10-Q · May 7, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 2.1× · EV/sales 2.6×. Comparisons use only industry-matched filing peers.
Scenario scaffold
Scenarios are withheld for Financial Services until sector-specific earnings and capital metrics are available; generic revenue/P/S scaffolds would be misleading.
Price action
How the market is pricing the story
115.58-0.3% today
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 7 Oct, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for APO. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for APO. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind APO
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ATH-PAFiling-linked namecustomerFeb 25, 2026 ▾
“For example, beginning in March 2024, a number of putative class actions were filed in federal courts in the U.S.”
ATH-PAFiling-linked nameinvesteeMay 7, 2026 ▾
“Athene’s primary market risk exposures are to credit risk, interest rate risk, equity price risk and inflation risk.”
Depended on by
MFICMidCap Financial Investment CorporationinvesteeMay 6, 2026 ▾
“Apollo Investment Management, L.P.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 11 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
APO is currently a Participant in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.